Inventor
MECHOULAM RAPHAEL
IL44 patents
⚠️ This page may combine multiple inventors who share the name “MECHOULAM RAPHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
23 patentsUS5538993AJul 23, 1996
Certain tetrahydrocannabinol-7-oic acid derivatives
YISSUM RES DEV CO115 citations96
US5932610AAug 3, 1999
Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals
YISSUM RES DEV CO63 citations95
US5434295AJul 18, 1995
Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds
YISSUM RES DEV CO91 citations95
US5284867AFeb 8, 1994
NMDA-blocking pharmaceutical compositions
YISSUM RES DEV CO57 citations95
US5635530AJun 3, 1997
(3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them
YISSUM RES DEV CO75 citations94
US4876276AOct 24, 1989
(3S-4S)-7-hydroxy-Δ6 -tetrahydrocannabinols
YISSUM RES DEV CO111 citations93
US6331560B1Dec 18, 2001
Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals
YISSUM RES DEV CO21 citations92
US4179517ADec 18, 1979
Novel tetrahydrocannabinol type compounds
YISSUM RES DEV CO64 citations92
US6903137B2Jun 7, 2005
Agonists specific for the peripheral cannabinoid receptor
YISSUM RES DEV CO28 citations90
US6864291B1Mar 8, 2005
Agonists specific for the peripheral cannabinoid receptor
YISSUM RES DEV CO27 citations90
US9447019B2Sep 20, 2016
Fluorinated CBD compounds, compositions and uses thereof
YISSUM RES DEV CO21 citations88
US5618955AApr 8, 1997
Fatty acid derivatives and pharmaceutical compositions containing same
YISSUM RES DEV CO85 citations88
US5605928AFeb 25, 1997
Antiemetic compositions
YISSUM RES DEV CO22 citations86
US9782360B2Oct 10, 2017
Fluorinated CBD compounds, compositions and uses thereof
YISSUM RES DEV CO12 citations80
US7759526B2Jul 20, 2010
Pharmaceutical compositions comprising cannabidiol derivatives
YISSUM RES DEV CO18 citations80
US6566543B2May 20, 2003
2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury
YISSUM RES DEV CO14 citations80
US6545041B2Apr 8, 2003
Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals
YISSUM RES DEV CO8 citations73
US7214716B2May 8, 2007
Agonists specific for the peripheral cannabinoid receptor
YISSUM RES DEV CO7 citations71
US6531636B1Mar 11, 2003
Synthetic endogenous cannabinoids analogues and uses thereof
YISSUM RES DEV CO8 citations67
US7884133B2Feb 8, 2011
Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives
YISSUM RES DEV CO2 citations61
US7749953B2Jul 6, 2010
Methods compositions and articles of manufacture for modulating bone growth
YISSUM RES DEV CO2 citations61
US9365534B2Jun 14, 2016
Arylated camphenes, processes for their preparation and uses thereof
YISSUM RES DEV CO1 citations49
US7407753B2Aug 5, 2008
Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
YISSUM RES DEV CO0 citations45
MECHOULAM RAPHAEL
6 patentsUS4282248AAug 4, 1981
Pinene derivatives and pharmaceutical compositions containing the same
MECHOULAM RAPHAEL61 citations94
US8119697B2Feb 21, 2012
Anti-nausea and anti-vomiting activity of cannabidiol compounds
MECHOULAM RAPHAEL25 citations90
US8497299B2Jul 30, 2013
Compositions including quinonoid derivatives of cannabinoids for therapeutic use
MECHOULAM RAPHAEL11 citations74
US4707559ANov 17, 1987
Analgetic and antiemetic compositions
MECHOULAM RAPHAEL8 citations72
US8722938B2May 13, 2014
Arylated camphenes, processes for their preparation and uses thereof
MECHOULAM RAPHAEL4 citations69
US8198327B2Jun 12, 2012
Fatty acid amides and uses thereof
MECHOULAM RAPHAEL3 citations55
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
6 patentsUS11149014B2Oct 19, 2021
Method for treating pain or associated condition or symptom
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations62
US10239848B2Mar 26, 2019
Cyclohexenyl compounds, compositions comprising them and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD1 citations62
US11058652B2Jul 13, 2021
Methods for treatment of Prader-Willi syndrome
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD1 citations55
US11440870B2Sep 13, 2022
Cannabidiolic acid esters compositions and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations53
US11324709B2May 10, 2022
Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations53
US10441553B2Oct 15, 2019
Fluorinated CBD compounds, compositions and uses thereof
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations48